Page 5 of 5
Organic Process Research & Development
lamivudine (3TC™) via a dynamic kinetic resolution, Tet.
Lett., 2005, 46, 8535-8538.
a) Watanabe, K.A.; Hollenberg, D.H.; Fox, J.J. Nucleosides.
1351-1354. b) Birman, V.B.; Li, X. Homobenzotetramisole:
an effective catalyst for kinetic resolution of aryl-
cycloalkanols, Org. Lett., 2008, 10, 1115-1118. c) Müller,
C.E.; Schreiner, P.R. Organocatalytic Enantioselective Acyl
Transfer onto Racemic as well as meso Alcohols, Amines, and
Thiols, Angew. Chem., Int. Ed., 2011, 50, 6012-6042. d) Ortiz,
A.; Benkovics, T.; Beutner, G.L.; Shi, Z.; Bultman, M.; Nye,
J.; Sfouggatakis, C.; Kronenthal, D.R. Scalable Synthesis of
the Potent HIV Inhibitor BMS‐986001 by Non‐Enzymatic
Dynamic Kinetic Asymmetric Transformation (DYKAT),
Angew. Chem., Int. Ed., 2015, 54, 7185-7188. e) Wang, H.-Y.,
Blaszcyk, S.A.; Xiao, G.; Tang, W. Chiral reagents in
glycosylation and modification of carbohydrates, Chem. Soc.
Rev., 2018, 47, 681.
1
2
3
4
5
6
7
8
9
3
)
8
5. On mechanisms of nucleoside synthesis by condensation
reactions, J. Carbohydr. Nucleos. Nucleot., 1974, 1, 1-37. b)
Wilson, L.J.; Hagar, M.W.; El-Kattan, Y.A.; Liotta, D.C.
Nitrogen lycosylation reactions involving pyrimidine and
purine nucleoside bases with furanoside sugars, Synthesis,
1
995, 12, 1465-1479. c) Mukaiyama, T.; Hirano, N.; Nishida,
M.; Uchiro, H. Catalytic stereoselective synthesis of
pyrimidine 2-deoxyribonucleosides, Chem. Lett., 1996, 25, 99-
100. d) McLaughlin, M.; Kong, J.; Belyk, K.M.; Chen, B.;
Gibson, A.W.; Keen, S.P.; Lieberman, D.R.; Milczek, E.M.;
Moore, J.C.; Murray, D.; Ji Qi, F.-P.; Reamer, R.A.; Song, Z.J.;
Tan, L.; Wang, L.; Williams, M.J. Enantioselective synthesis
of 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) via
enzymatic desymmetrization, Org. Lett., 2017, 19, 926-929.
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
10) a) Fleer, M.P.M.; Verkuijl, B.J.V. Optimization of the use of a
chiral bio-based building block for the manufacture of
DHPPA, a key intermediate for propionate herbicides, Green
4) a) Jeong, L.S.; Schinazi, R.F.; Beach, W.J.; Kim, H.O.;
Nampallia, S.; Shanmuganathan, K.; Alves, A.J.; McMillan,
A.; Chu, C.K.; Mathis, R. Asymmetric synthesis and biological
evaluation of β-L-(2R,5S)- and α-L-(2R,5R)-1,3-oxathiolane-
pyrimidine and -purine nucleosides as potential anti-HIV
agents, J. Med. Chem., 1993, 36, 181-195. b) Hu, L.;
Schaufelberger, F.; Zhang, Y.; Ramström, O. Efficient
asymmetric synthesis of lamivudine via enzymatic dynamic
kinetic resolution, Chem. Commun., 2013, 49, 10376-10378.
Chem., 2014, 16, 3993-3998.
b) Whittingham, W.G.
Herbicidal Aryloxyphenoxypropionate Inhibitors of Acetyl-
CoA Carboxylase in Bioactive Carboxylic Compound Classes:
Pharmaceuticals and Agrochemicals; Lamberth, C.; Dinges,
J., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinham,
Germany, 2016, 325-337.
11) a) Baltes, H.; Leupold, E.I.; Wunder, F. Process for the
manufacture of glyoxylic acid esters, US4340748, 1982. b)
Dyroff, D. R.; Chou, Y.; Cova, D.R. Production of high purity
alkyl glyoxylate by plural stage distillation, US4502923, 1985.
c) Baba, H.; Miura, S.; Nonoguchi, M.; Saito, N. Method of
purifying glyoxylic esters and distillation equipment for
purifying glyoxylic esters, US6037489, 1996. d) Hayashi, T.;
Inagaki, T. Catalyst for the preparation of carboxylic esters and
method for producing carboxylic esters, US7326806, 2002.
12) Jung, M.E.; Shishido, K.; Davis, L.H. Simple syntheses of
diethyl oxomalonate and alkyl glyoxylates, J. Org. Chem.,
1982, 47, 891-892.
13) a) Nobis, M.; Roberge, D.M. Mastering ozonolysis: production
from laboratory to ton scale in continuous flow, Chim. Oggi,
2009, 29, 56-58. b) Allian, A.D.; Richter, S.M.; Kallemeyn,
J.M.; Robbins, T.A.; Kishore, V. The development of
continuous process for alkene ozonolysis based on combined
in situ FTIR, calorimetry, and computational chemistry, Org.
Process Res. Dev., 2011, 15, 91-97. c) Fisher, T.J.; Dussault,
P.H. Alkene ozonolysis, Tet., 2017, 73, 4233-4258.
14) Caso, M.F.; D’Alonzo, D.; D’Errico, S.; Palumbo, G.;
Guaragna, A. Highly Stereoselective Synthesis of Lamivudine
(3TC) and Emtricitabine (FTC) by a Novel N-Glycosidation
Procedure, Org. Lett., 2015, 17, 2626-2629.
15) a) da Silva, C.C.; Coelho, R.R.; Cirqueira, M.L.; de Melo,
A.C.C.; Rosa, I.M.L.; Ellena, J.; Martins, F.T. Salts of the anti-
HIV drug lamivudine with phthalic and salicylic acids,
CrystEngComm, 2012, 14, 4562-4566. b) Perumalla, S.R.;
Sun, C.C. Significant expansion of the solid state landscape of
salicylic acid based on charge-assisted hydrogen bonding
interactions, Cryst. Growth Des., 2014, 14, 3990-3995.
5
)
a) Hoong, L.K.; Strange, L.E.; Liotta, D.C. Enzyme-mediated
enantioselective preparation of pure enantiomers of the
antiviral agent 2', 3'-dideoxy-5-fluoro-3'-thiacytidine (FTC)
and related compounds, J. Org. Chem., 1992, 57, 5563-5565.
b) Mahmoudian, M.; Baines, B.S.; Drake, C.S.; Hale, R.S.;
Jones, P.; Piercey, J.E.; Montgomery, D.S.; Purvis, I.J.; Storer,
R.; Dawson, M.J.; Lawrence, G.C. Enzymatic production of
optically pure (2′ R-cis)-2′-deoxy-3′-thiacytidine (3TC,
Lamivudine): A potent anti-HIV agent, Enzyme Microb.
Technol., 1993, 15, 749-755. c) Milton, J.; Brand, S.; Jones,
M.F.; Rayner, C.M. Enzymatic Resolution of α-
acetoxysulfides:
A new approach to the synthesis of
homochiral S, O-Acetals, Tet. Asymm., 1995, 6, 1903-1906. d)
Milton, J.; Brand, S.; Jones, M.F.; Rayner, C.M. Tet. Lett.,
1
995, 36, 6961-6964. e) Cousins, R.P.C.; Mahmoudian, M.;
Youds, P.M. Enantioselective enzymatic synthesis of the anti-
viral agent lamivudine (3TC™), Tet. Asymm., 1995, 6, 393-
396. f) Jin, H.; Siddiqui, A.; Evans, C.A.; Tse, H.L.A.;
Mansour, T.S. Diastereoselective synthesis of the potent
antiviral agent (-)-2'-deoxy-3'-thiacytidine and its enantiomer,
J. Org. Chem., 1995, 60, 2621-2623. g) Li, J.-Z.; Gao, L.-X.;
Ding, M.-X. The chemical resolution of racemic cis-2-
hydroxymethyl-5-(cytosine-1′-yl)-1,3-oxathiolane
(BCH-
189)—One direct method to obtain lamivudine as anti-HIV and
anti-HBV agent, Synth. Commun., 2002, 32, 2355-2359. h)
Roy, B.N.; Singh, G.P.; Srivastava, D.; Jadhav, H.S.; Saini,
M.B.; Aher, U.P. A Novel Method for Large-Scale Synthesis
of Lamivudine through Cocrystal Formation of Racemic
Lamivudine with (S)-(−)-1,1′-Bi(2-naphthol) [(S)-(BINOL)],
Org. Process Res. Dev., 2009, 13, 450-455. i) Reddy, B.P.;
Reddy, K.R.; Reddy, R.R.; Reddy, D.M.; Srinivas, A.S.
Optical resolution of substituted 1,3-oxathiolane nucleosides,
US20110245497, 2011.
6
)
a) Knapp, S. Synthesis of complex nucleoside antibiotics,
Chem. Rev., 1995, 95, 1859-1876. b) Romeo, G.; Chiacchio,
U.; Corsaro, A.; Merino, P. Chemical synthesis of
heterocyclic− sugar nucleoside analogues, Chem. Rev., 2010,
1
10, 3337-3370.
7
8
)
)
Sakakura, A.; Kawajiri, K.; Ohkubo, T.; Kosugi, Y.; Ishihara,
K. Widely useful DMAP-catalyzed esterification under
auxiliary base-and solvent-free conditions, J. Am. Chem. Soc.,
2
007, 129, 14775-14779.
See Supporting Information for details regarding optimization
of synthesis.
9) a) Birman, V.B.; Li, X. Benzotetramisole: A remarkably
enantioselective acyl transfer catalyst, Org. Lett., 2006, 8,
5
ACS Paragon Plus Environment